The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia (2024)
- Authors:
- USP affiliated authors: GOMES, FELIPE VILLELA - FMRP ; LISBÔA, JOÃO ROBERTO FERNANDES - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bcp.2024.116298
- Subjects: NEURÔNIOS; FÁRMACOS; FARMACOLOGIA; NEUROTRANSMISSORES; NEURÔNIOS
- Keywords: Schizophrenia; Excitatory-inhibitory balance; PV interneuron
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2024
- Source:
- Título: Biochemical Pharmacology
- ISSN: 0006-2952
- Volume/Número/Paginação/Ano: v. 228, art. 116298, p. 1-13, 2024
- Este periódico possui versão em assinatura (ou híbrida)
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão: submittedVersion
- Evidência: deprecated
- Status do Acesso Aberto: green
-
ABNT
ULIANA, Daniela L. et al. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology, v. 228, p. 1-13, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2024.116298. Acesso em: 10 mar. 2026. -
APA
Uliana, D. L., Lisboa, J. R. F., Gomes, F. V., & Grace, A. A. (2024). The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology, 228, 1-13. doi:10.1016/j.bcp.2024.116298 -
NLM
Uliana DL, Lisboa JRF, Gomes FV, Grace AA. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia [Internet]. Biochemical Pharmacology. 2024 ; 228 1-13.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1016/j.bcp.2024.116298 -
Vancouver
Uliana DL, Lisboa JRF, Gomes FV, Grace AA. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia [Internet]. Biochemical Pharmacology. 2024 ; 228 1-13.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1016/j.bcp.2024.116298 - MMP-9 as a marker for the association between childhood/adolescent trauma and psychosis
- Perineuronal net density in schizophrenia: a systematic review of postmortem brain studies
- Cannabidiol as an antipsychotic drug
- Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure
- Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia
- Stress during critical periods of development and risk for schizophrenia
- Prelimbic medial prefrontal cortex disruption during adolescence increases susceptibility to helpless behavior in adult rats
- Cortical dopamine dysregulation in schizophrenia and its link to stress. [Carta]
- GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia
- Altered ventral striatum–hippocampus connectivity during reward processing as an endophenotype for psychosis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
